Welcome to BusinessBankruptcies.com!

Sign up for a free account to get access to data on case creditors, search for cases, and more.

Scintilla Pharmaceuticals, Inc.

COURT
Texas Southern Bankruptcy Court
CASE NUMBER
4:2023bk90084
TYPE / CHAPTER
Voluntary / 11

Subscribe to This Case

Follow this case and receive case update emails for the life of this case for a one-time fee of $39.95.

Case Information

This case has a LEAD CASE: Sorrento Therapeutics, Inc.

When following such a bankruptcy, it is important to follow the lead case. When we detect a group of jointly administered cases, we mark the associated and lead cases. The case information tab of the case page will show whether a case is associated with a lead case, or is a lead case and has associated cases.

Filed

2-13-23

Updated

3-31-24

Last Checked

2-14-23

Assets

Subscribe

Liabilities

Subscribe

Get notified when your customers file for bankruptcy

Docket

Last Updated
Feb 14, 2023
Last Entry Filed
Feb 14, 2023

Docket Entries by Month

Feb 13, 2023 1 Petition Chapter 11 Voluntary Petition Non-Individual Fee Amount $1738 Filed by Scintilla Pharmaceuticals, Inc.. (Cavenaugh, Matthew) (Entered: 02/13/2023)
Feb 13, 2023 2 Notice and Order regarding exchanging of exhibits and witness lists in all contested matters and adversary proceedings. (Entered: 02/13/2023)
Feb 13, 2023 3 Order for Joint Administration Signed on 2/13/2023 (Related Doc # 2). (AlbertAlonzo) (Entered: 02/13/2023)
Feb 13, 2023 4 Notice of Appearance and Request for Notice Filed by Patricia Baron Tomasco Filed by on behalf of NantCell, Inc. and Immunotherapy NANTibody LLC (Tomasco, Patricia) (Entered: 02/13/2023)
Feb 14, 2023 Receipt of Voluntary Petition (Chapter 11)( 23-90084) [misc,volp11] (1738.00) Filing Fee. Receipt number A24200012. Fee amount $1738.00. (U.S. Treasury) (Entered: 02/14/2023)

Case Information

Court
Texas Southern Bankruptcy Court
Case number
4:2023bk90084
Assets
Subscribe for Access
Liabilities
Subscribe for Access
Judge
David R Jones
Chapter
11
Filed
Feb 13, 2023
Type
voluntary
Updated
Mar 31, 2024
Last checked
Feb 14, 2023
Lead case
Sorrento Therapeutics, Inc.

Associated Cases

    This case has no creditors listed.

    Parties

    Debtor

    Scintilla Pharmaceuticals, Inc.
    7 Switchbud Place
    Suite 192-513
    PO Box 513
    The Woodlands, TX 77380
    MONTGOMERY-TX
    Tax ID / EIN: xx-xxx7956

    Represented By

    Matthew D Cavenaugh
    Jackson Walker LLP
    1401 McKinney Street
    Ste 1900
    Houston, TX 77010
    713-752-4200
    Email: mcavenaugh@jw.com

    U.S. Trustee

    US Trustee
    Office of the US Trustee
    515 Rusk Ave
    Ste 3516
    Houston, TX 77002

    Nearby Cases

    Date Filed Nameparent case = parent case Chapter Case #
    Jul 27, 2023 Candy Club Investment, LLC parent case 11V 6:2023bk60047
    Jul 23, 2023 AppHarvest Products, LLC 11 4:2023bk90745
    Jul 23, 2023 AppHarvest Products, LLC parent case 11 9:2023bk90745
    Jun 19, 2023 Pioneer Surgical Technology NewCo Inc. parent case 11 4:2023bk90734
    Jun 19, 2023 Spinal Transition and Professional Services LLC parent case 11 4:2023bk90730
    Jun 19, 2023 Pioneer Surgical Technology NewCo Inc. parent case 11 9:2023bk90734
    Jun 19, 2023 Spinal Transition and Professional Services LLC parent case 11 9:2023bk90730
    Aug 23, 2021 Branded Asset Management Group, LLC 7 4:2021bk32788
    Jun 29, 2018 Park Ten Investments, LLC 11 4:2018bk33502
    Jan 27, 2017 1776 American Properties VIII LLC parent case 11 4:17-bk-30427
    Jan 27, 2017 1776 American Properties VII LLC parent case 11 4:17-bk-30426
    Jan 27, 2017 1776 American Properties VI LLC parent case 11 4:17-bk-30425
    Jan 27, 2017 1776 American Properties V LLC parent case 11 4:17-bk-30424
    Jan 27, 2017 1776 American Properties IV LLC 11 4:17-bk-30422
    Nov 19, 2015 Cartwright Wood Products, LLC 7 4:15-bk-36077